Skip to main content
Premium Trial:

Request an Annual Quote

Applied Precision Makes Ownership Changes, Posts New CEO

NEW YORK, Feb. 1 - Boston investment firm Riverside Partners has taken a "significant" minority ownership position in Applied Precision and will post three representatives to a new nine-member management board, the company said in a statement today.


Under the new organization, company co-founder Ron Seubert, an electronic engineer, becomes CEO and a board member. The company's other two founders, Don Snow and John Stewart, will also sit on the new management board, but will be less involved in daily operations of the company; Snow will work half-time, and Stewart has retired.


The board will also include three industry experts from pharma, life sciences and semiconductors.


In addition, Applied Precision has reformulated as an LLC.


Riverside representatives will not directly manage the company, but will assist in strategic alliances for development, distribution and investment.


The investment firm's new stake in Applied Precision was not disclosed.


The Issaquah, Wash., company develops tools for measurement and analysis in biotech, communications and computing, including a biochip reader and live-cell microscopy systems.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more